Morgan Lewis represented Nevakar Inc. in a product financing agreement with an affiliate of H.I.G. Capital Partners LP for the continued development of five differentiated, sterile injectable products.
Nevakar is a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas. H.I.G. is a global private equity and alternative assets investment firm with more than $34 billion of equity capital under management.
Partner Joanne Soslow and associate Conor Larkin led the Morgan Lewis team advising Nevakar.